Failure to detect autologous antibodies in the remission sera of patients with AML: complications introduced by the presence of rheumatoid factor.

Sera were collected from patients with acute myelogenous leukaemia (AML) at various times during remission induced by chemotherapy, but after cessation of all immunosupressive treatment. These sera were tested, by a sensitive assay using radio-labelled antiglobulin binding, for the presence of antib...

Full description

Bibliographic Details
Main Authors: James, S. E., Dean, C. J., Alexander, P.
Format: Online
Language:English
Published: 1980
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010419/